Detalhe da pesquisa
1.
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study.
J Med Virol
; 95(7): e28933, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37403897
2.
Features of cytomegalovirus DNAemia and virus-specific T-cell responses in allogeneic hematopoietic stem-cell transplant recipients during prophylaxis with letermovir.
Transpl Infect Dis
; 25(2): e14021, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748748
3.
Impact of cytomegalovirus immunodominant HLA-I donor-recipient matching on the incidence and features of virus DNAemia and virus-specific T-cell immune reconstitution in unmanipulated haploidentical hematopoietic stem cell transplantation.
Transpl Infect Dis
; 25(3): e14065, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120821
4.
Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid-resistant acute and chronic graft-vs-host disease after allogenic hematopoietic stem cell transplant.
J Clin Apher
; 36(5): 697-710, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34185332
5.
Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine.
Ann Hematol
; 99(3): 527-537, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31989250
6.
Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.
Med Microbiol Immunol
; 208(3-4): 405-414, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30911925
7.
Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors.
Br J Haematol
; 200(6): e58-e61, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652997
8.
Therapy-related acute myeloid leukemia developing 14â¯years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin.
Exp Mol Pathol
; 105(1): 139-143, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30017658
9.
Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison.
Mycoses
; 61(3): 206-212, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29125660
10.
IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients.
J Med Virol
; 89(4): 685-695, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27591738
11.
Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients.
Transpl Infect Dis
; 19(4)2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28471073
12.
Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib.
Br J Haematol
; 195(4): 637-641, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34402042
13.
Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera.
Eur J Haematol
; 96(3): 285-90, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25996073
14.
Lack of evidence for a reciprocal interaction between bacterial and cytomegalovirus infection in the allogeneic stem cell transplantation setting.
Transpl Int
; 29(11): 1196-1204, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27529151
15.
Role of cytomegalovirus (CMV)-specific polyfunctional CD8+ T-cells and antibodies neutralizing virus epithelial infection in the control of CMV infection in an allogeneic stem-cell transplantation setting.
J Gen Virol
; 96(9): 2822-2831, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26025872
16.
Plasma metabolomics profiling for the prediction of cytomegalovirus DNAemia and analysis of virushost interaction in allogeneic stem cell transplant recipients.
J Gen Virol
; 96(11): 3373-3381, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341195
17.
Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.
J Med Virol
; 87(2): 248-55, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25132583
18.
Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
J Med Virol
; 87(9): 1601-7, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25802229
19.
Failure of Cytomegalovirus-Specific CD8+ T Cell Levels at Viral DNAemia Onset to Predict the Eventual Need for Preemptive Antiviral Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
J Infect Dis
; 219(9): 1510-1512, 2019 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30597050
20.
Monitoring of trough plasma ganciclovir levels and peripheral blood cytomegalovirus (CMV)-specific CD8+ T cells to predict CMV DNAemia clearance in preemptively treated allogeneic stem cell transplant recipients.
Antimicrob Agents Chemother
; 58(9): 5602-5, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24982073